2018-07442. Importer of Controlled Substances Application: Lipomed  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 11, 2018. Such persons may also file a written request for a Start Printed Page 15628hearing on the application on or before May 11, 2018.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

    In accordance with 21 CFR 1301.34(a), this is notice that on January 22, 2016, Lipomed, 150 Cambridge Park Drive, Suite 705, Cambridge, MA 02140 applied to be registered as an importer of the following basic classes of controlled substances:

    Controlled substanceDrug codeSchedule
    Cathinone1235I.
    Methcathinone1237I.
    Mephedrone (4-Methyl-N-methylcathinone)1248I.
    N-Ethylamphetamine1475I.
    N,N-Dimethylamphetamine1480I.
    Fenethylline1503I.
    Aminorex1585I.
    4-Methylaminorex (cis isomer)1590I.
    Gamma Hydroxybutyric Acid2010I.
    Methaqualone2565I.
    Mecloqualone2572I.
    JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)6250I.
    SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole)7008I.
    JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)7019I.
    JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole)7081I.
    SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole7104I.
    JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)7118I.
    JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole)7122I.
    JWH-073 (1-Butyl-3-(1-naphthoyl)indole)7173I.
    JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)7200I.
    AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)7201I.
    JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole)7203I.
    Alpha-ethyltryptamine7249I.
    Ibogaine7260I.
    CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)7297I.
    CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)7298I.
    Lysergic acid diethylamide7315I.
    2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)7348I.
    Marihuana7360I.
    Tetrahydrocannabinols7370I.
    Parahexyl7374I.
    Mescaline7381I.
    2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 )7385I.
    3,4,5-Trimethoxyamphetamine7390I.
    4-Bromo-2,5-dimethoxyamphetamine7391I.
    4-Bromo-2,5-dimethoxyphenethylamine7392I.
    4-Methyl-2,5-dimethoxyamphetamine7395I.
    2,5-Dimethoxyamphetamine7396I.
    JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole)7398I.
    2,5-Dimethoxy-4-ethylamphetamine7399I.
    3,4-Methylenedioxyamphetamine7400I.
    5-Methoxy-3,4-methylenedioxyamphetamine7401I.
    N-Hydroxy-3,4-methylenedioxyamphetamine7402I.
    3,4-Methylenedioxy-N-ethylamphetamine7404I.
    3,4-Methylenedioxymethamphetamine7405I.
    4-Methoxyamphetamine7411I.
    5-Methoxy-N-N-dimethyltryptamine7431I.
    Alpha-methyltryptamine7432I.
    Bufotenine7433I.
    Psilocybin7437I.
    Psilocyn7438I.
    5-Methoxy-N,N-diisopropyltryptamine7439I.
    N-Ethyl-1-phenylcyclohexylamine7455I.
    1-[1-(2-Thienyl)cyclohexyl]piperidine7470I.
    1-[1-(2-Thienyl)cyclohexyl]pyrrolidine7473I.
    Start Printed Page 15629
    N-Ethyl-3-piperidyl benzilate7482I.
    N-Methyl-3-piperidyl benzilate7484I.
    N-Benzylpiperazine7493I.
    2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)7508I.
    2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E )7509I.
    2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)7517I.
    2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)7518I.
    2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)7519I.
    2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)7521I.
    2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)7524I.
    2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4)7532I.
    MDPV (3,4-Methylenedioxypyrovalerone)7535I.
    Methylone (3,4-Methylenedioxy-N-methylcathinone)7540I.
    AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)7694I.
    Acetyldihydrocodeine9051I.
    Benzylmorphine9052I.
    Codeine-N-oxide9053I.
    Cyprenorphine9054I.
    Desomorphine9055I.
    Etorphine (except HCl)9056I.
    Codeine methylbromide9070I.
    Dihydromorphine9145I.
    Difenoxin9168I.
    Heroin9200I.
    Hydromorphinol9301I.
    Methyldesorphine9302I.
    Methyldihydromorphine9304I.
    Morphine methylbromide9305I.
    Morphine methylsulfonate9306I.
    Morphine-N-oxide9307I.
    Myrophine9308I.
    Nicocodeine9309I.
    Nicomorphine9312I.
    Normorphine9313I.
    Pholcodine9314I.
    Thebacon9315I.
    Acetorphine9319I.
    Acetylmethadol9601I.
    Allylprodine9602I.
    Alphacetylmethadol except levo-alphacetylmethadol9603I.
    Alphamethadol9605I.
    Dioxaphetyl butyrate9621I.
    Dipipanone9622I.
    Ethylmethylthiambutene9623I.
    Etonitazene9624I.
    Etoxeridine9625I.
    Furethidine9626I.
    Hydroxypethidine9627I.
    Ketobemidone9628I.
    Levomoramide9629I.
    Levophenacylmorphan9631I.
    Morpheridine9632I.
    Noracymethadol9633I.
    Norlevorphanol9634I.
    Normethadone9635I.
    Norpipanone9636I.
    Phenadoxone9637I.
    Phenampromide9638I.
    Phenoperidine9641I.
    Piritramide9642I.
    Proheptazine9643I.
    Properidine9644I.
    Racemoramide9645I.
    Trimeperidine9646I.
    Phenomorphan9647I.
    Propiram9649I.
    Tilidine9750I.
    Para-Fluorofentanyl9812I.
    3-Methylfentanyl9813I.
    Acetyl-alpha-methylfentanyl9815I.
    Beta-hydroxy-3-methylfentanyl9831I.
    Amphetamine1100II.
    Methamphetamine1105II.
    Lisdexamfetamine1205II.
    Start Printed Page 15630
    Phenmetrazine1631II.
    Methylphenidate1724II.
    Amobarbital2125II.
    Pentobarbital2270II.
    Secobarbital2315II.
    Glutethimide2550II.
    Nabilone7379II.
    1-Phenylcyclohexylamine7460II.
    Phencyclidine7471II.
    4-Anilino-N-phenethyl-4-piperidine (ANPP)8333II.
    Phenylacetone8501II.
    1-Piperidinocyclohexanecarbonitrile8603II.
    Alphaprodine9010II.
    Anileridine9020II.
    Cocaine9041II.
    Codeine9050II.
    Etorphine HCl9059II.
    Dihydrocodeine9120II.
    Oxycodone9143II.
    Hydromorphone9150II.
    Diphenoxylate9170II.
    Ecgonine9180II.
    Ethylmorphine9190II.
    Hydrocodone9193II.
    Levomethorphan9210II.
    Levorphanol9220II.
    Isomethadone9226II.
    Meperidine9230II.
    Meperidine intermediate-B9233II.
    Metazocine9240II.
    Methadone9250II.
    Methadone intermediate9254II.
    Metopon9260II.
    Dextropropoxyphene, bulk (non-dosage forms)9273II.
    Morphine9300II.
    Thebaine9333II.
    Dihydroetorphine9334II.
    Levo-alphacetylmethadol9648II.
    Oxymorphone9652II.
    Noroxymorphone9668II.
    Phenazocine9715II.
    Piminodine9730II.
    Racemethorphan9732II.
    Racemorphan9733II.
    Alfentanil9737II.
    Remifentanil9739II.
    Sufentanil9740II.
    Carfentanil9743II.
    Tapentadol9780II.
    Bezitramide9800II.
    Fentanyl9801II.

    The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale.

    Start Signature

    Dated: April 4, 2018.

    Susan A. Gibson,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2018-07442 Filed 4-10-18; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
04/11/2018
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2018-07442
Dates:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 11, 2018. Such persons may also file a written request for a hearing on the application on or before May 11, 2018.
Pages:
15627-15630 (4 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2018-07442.pdf